Premium
A case of emphysematous pyelonephritis in a patient with rheumatoid arthritis taking corticosteroid and low‐dose methotrexate
Author(s) -
WATANABE Hiroshi,
SUZUKI Ryoma,
ASANO Tomoyuki,
SHIO Kiori,
IWADATE Haruyo,
KOBAYASHI Hiroko,
MATSUOKA Toshimitsu,
AIKAWA Ken,
OHIRA Hiromasa
Publication year - 2010
Publication title -
international journal of rheumatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 41
eISSN - 1756-185X
pISSN - 1756-1841
DOI - 10.1111/j.1756-185x.2010.01460.x
Subject(s) - medicine , methotrexate , rheumatoid arthritis , corticosteroid , adverse effect , diabetes mellitus , arthritis , autoimmune disease , gastroenterology , disease , immunology , endocrinology
Rheumatoid arthritis (RA) is a systemic autoimmune disease that is characterized by chronic synovial inflammation. Patients with RA have increased risk of infection; this is related to RA itself or the adverse effects of medication. In this report, we describe a case of emphysematous pyelonephritis in a patient with RA associated with AA amyloidosis and steroid‐induced diabetes mellitus who was taking corticosteroid and low‐dose methotrexate.